Chengdu Bright Eye Hospital Group expects a significant decline in net profit in 2024, facing severe financial challenges

On January 17th, Chengdu Bright Eye Hospital Group (301239.SZ) released its performance forecast for 2024, expecting a net loss of between 80 million yuan and 120 million yuan, a shift from profit to loss compared to the same period last year. In addition, the net loss after deducting non-recurring gains and losses is expected to be between 60 million yuan and 90 million yuan, indicating that the financial situation is also not optimistic.

According to financial report data, Chengdu Bright Eye Hospital Group's revenue for the first three quarters of 2024 was approximately 2.137 billion yuan, a year-on-year decrease of 1.36%; the net profit attributable to shareholders of the listed company was approximately 15.84 million yuan, a significant year-on-year decline of 95.01%; the basic earnings per share were 0.11 yuan, a year-on-year decrease of 94.81%.

This performance forecast reflects the significant increase in operational pressure faced by Chengdu Bright Eye Hospital Group in 2024, and the company may face more challenges in the future